These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 28870929)

  • 1. Diffusion-weighted MRI Provides a Useful Biomarker for Evaluation of Radiotherapy Efficacy in Patients with Prostate Cancer.
    Wu X; Reinikainen P; Kapanen M; Vierikko T; Ryymin P; Kellokumpu-Lehtinen PL
    Anticancer Res; 2017 Sep; 37(9):5027-5032. PubMed ID: 28870929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffusion-weighted magnetic resonance imaging in patients with prostate cancer treated with radiotherapy.
    Iannelli G; Caivano R; Rago L; Simeon V; Lotumolo A; Rabasco P; Villonio A; Gioioso M; Mastrangelo P; Barchetti F; Panebianco V; Macarini L; Guglielmi G; Cammarota A
    Tumori; 2016; 102(1):71-6. PubMed ID: 26350197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of response to radiotherapy for prostate cancer: value of diffusion-weighted MRI at 3 T.
    Song I; Kim CK; Park BK; Park W
    AJR Am J Roentgenol; 2010 Jun; 194(6):W477-82. PubMed ID: 20489065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensity-modulated radiotherapy of the prostate: dynamic ADC monitoring by DWI at 3.0 T.
    Decker G; Mürtz P; Gieseke J; Träber F; Block W; Sprinkart AM; Leitzen C; Buchstab T; Lütter C; Schüller H; Schild HH; Willinek WA
    Radiother Oncol; 2014 Oct; 113(1):115-20. PubMed ID: 25304719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Diffusion Kurtosis Imaging Versus Standard Diffusion Imaging for Detection and Grading of Peripheral Zone Prostate Cancer.
    Roethke MC; Kuder TA; Kuru TH; Fenchel M; Hadaschik BA; Laun FB; Schlemmer HP; Stieltjes B
    Invest Radiol; 2015 Aug; 50(8):483-9. PubMed ID: 25867657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between apparent diffusion coefficient value on diffusion-weighted MR imaging and Gleason score in prostate cancer.
    Wu X; Reinikainen P; Vanhanen A; Kapanen M; Vierikko T; Ryymin P; Hyödynmaa S; Kellokumpu-Lehtinen PL
    Diagn Interv Imaging; 2017 Jan; 98(1):63-71. PubMed ID: 27687831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apparent diffusion coefficient value and ratio as noninvasive potential biomarkers to predict prostate cancer grading: comparison with prostate biopsy and radical prostatectomy specimen.
    De Cobelli F; Ravelli S; Esposito A; Giganti F; Gallina A; Montorsi F; Del Maschio A
    AJR Am J Roentgenol; 2015 Mar; 204(3):550-7. PubMed ID: 25714284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffusion-weighted MRI of peripheral zone prostate cancer: comparison of tumor apparent diffusion coefficient with Gleason score and percentage of tumor on core biopsy.
    Woodfield CA; Tung GA; Grand DJ; Pezzullo JA; Machan JT; Renzulli JF
    AJR Am J Roentgenol; 2010 Apr; 194(4):W316-22. PubMed ID: 20308476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring radiotherapy induced tissue changes in localized prostate cancer by multi-parametric magnetic resonance imaging (MP-MRI).
    Wu X; Reinikainen P; Kapanen M; Vierikko T; Ryymin P; Kellokumpu-Lehtinen PL
    Diagn Interv Imaging; 2019 Nov; 100(11):699-708. PubMed ID: 31257114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early changes in apparent diffusion coefficient from diffusion-weighted MR imaging during radiotherapy for prostate cancer.
    Park SY; Kim CK; Park BK; Park W; Park HC; Han DH; Kim B
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):749-55. PubMed ID: 22154286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incremental value of high b value diffusion-weighted magnetic resonance imaging at 3-T for prediction of extracapsular extension in patients with prostate cancer: preliminary experience.
    Kido A; Tamada T; Sone T; Kanomata N; Miyaji Y; Yamamoto A; Ito K
    Radiol Med; 2017 Mar; 122(3):228-238. PubMed ID: 27943099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apparent diffusion coefficient values are superior to transrectal ultrasound-guided prostate biopsy for the assessment of prostate cancer aggressiveness.
    Li C; Chen M; Wang J; Wang X; Zhang W; Zhang C
    Acta Radiol; 2017 Feb; 58(2):232-239. PubMed ID: 27055916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-resolution diffusion-weighted imaging of the prostate.
    Medved M; Soylu-Boy FN; Karademir I; Sethi I; Yousuf A; Karczmar GS; Oto A
    AJR Am J Roentgenol; 2014 Jul; 203(1):85-90. PubMed ID: 24951199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose painting of prostate cancer based on Gleason score correlations with apparent diffusion coefficients.
    Grönlund E; Johansson S; Nyholm T; Thellenberg C; Ahnesjö A
    Acta Oncol; 2018 May; 57(5):574-581. PubMed ID: 29260950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Utility of diffusion-weighted magnetic resonance imaging and apparent diffusion coefficient in detection of prostate cancer and prediction of pathologic Gleason score].
    Kagebayashi Y; Nakai Y; Matsumoto Y; Samma S; Miyasaka T; Nakagawa H
    Hinyokika Kiyo; 2012 Aug; 58(8):405-8. PubMed ID: 23052263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pilot Study of the Use of Hybrid Multidimensional T2-Weighted Imaging-DWI for the Diagnosis of Prostate Cancer and Evaluation of Gleason Score.
    Sadinski M; Karczmar G; Peng Y; Wang S; Jiang Y; Medved M; Yousuf A; Antic T; Oto A
    AJR Am J Roentgenol; 2016 Sep; 207(3):592-8. PubMed ID: 27352026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffusion-weighted endorectal MR imaging at 3T for prostate cancer: correlation with tumor cell density and percentage Gleason pattern on whole mount pathology.
    Glazer DI; Hassanzadeh E; Fedorov A; Olubiyi OI; Goldberger SS; Penzkofer T; Flood TA; Masry P; Mulkern RV; Hirsch MS; Tempany CM; Fennessy FM
    Abdom Radiol (NY); 2017 Mar; 42(3):918-925. PubMed ID: 27770164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diffusion-weighted MRI treatment monitoring of primary hypofractionated proton and carbon ion prostate cancer irradiation using raster scan technique.
    Wolf MB; Edler C; Tichy D; Röthke MC; Schlemmer HP; Herfarth K; Bonekamp D
    J Magn Reson Imaging; 2017 Sep; 46(3):850-860. PubMed ID: 28152251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative Evaluation of Prostate Cancer Aggressiveness: Using ADC and ADC Ratio in Determining Gleason Score.
    Woo S; Kim SY; Cho JY; Kim SH
    AJR Am J Roentgenol; 2016 Jul; 207(1):114-20. PubMed ID: 27077643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic utility of diffusion-weighted MRI in oesophageal cancer: is apparent diffusion coefficient a potential marker of tumour aggressiveness?
    Giganti F; Salerno A; Ambrosi A; Chiari D; Orsenigo E; Esposito A; Albarello L; Mazza E; Staudacher C; Del Maschio A; De Cobelli F
    Radiol Med; 2016 Mar; 121(3):173-80. PubMed ID: 26392393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.